HeartSciences (HSCS) Income from Continuing Operations (2021 - 2026)
HeartSciences' (HSCS) quarterly Income from Continuing Operations came in at 2764715.0 in Q2 2026, down 31.57% YoY from 4040487.33 in Q2 2025, and down 17.5% on a QoQ basis from 2352937.0 in Q4 2025.
HeartSciences (HSCS) Income from Continuing Operations (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has 6 years of Income from Continuing Operations data on file, last reported at 2764715.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 31.57% year-over-year to 2764715.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 24554686.0 (up 51.66% YoY) and the FY2026 annual result came in at 25765152.0, down 10.19% from the prior year.
- Income from Continuing Operations eased to 2764715.0 in Q2 2026, from 2352937.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1239354.0 in Q1 2022 to a low of 17335783.0 in Q3 2025.
- A 5-year average of 9323960.76 and a median of 12433010.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1476.03% — and 2025, when it surged 85.34%.
- Tracing HSCS's Income from Continuing Operations over 5 years: stood at 12542933.0 in 2022, then retreated by 11.23% to 13951559.0 in 2023, then dropped by 15.02% to 16047179.0 in 2024, then surged by 85.34% to 2352937.0 in 2025, then fell by 17.5% to 2764715.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2764715.0 (Q2 2026), 2352937.0 (Q4 2025), and 17335783.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | HeartSciences | 6.64 Mn | 4.94 Mn | - | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2.76 Mn |
| Oct 31, 2025 | -2.35 Mn |
| Jul 31, 2025 | -17.34 Mn |
| Apr 30, 2025 | -2.10 Mn |
| Jan 31, 2025 | -16.96 Mn |
| Oct 31, 2024 | -16.05 Mn |
| Jul 31, 2024 | -15.68 Mn |
| Apr 30, 2024 | -1.90 Mn |
| Jan 31, 2024 | -14.30 Mn |
| Oct 31, 2023 | -13.95 Mn |
| Jul 31, 2023 | -13.35 Mn |
| Apr 30, 2023 | -1.63 Mn |
| Jan 31, 2023 | -12.43 Mn |
| Oct 31, 2022 | -12.54 Mn |
| Jul 31, 2022 | -11.85 Mn |
| Apr 30, 2022 | -2.05 Mn |
| Jan 31, 2022 | -1.24 Mn |
| Oct 31, 2021 | -1.03 Mn |
| Jul 31, 2021 | -752,051.00 |